Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in Semin Oncol

Retrieve available abstracts of 18 articles:
HTML format
Text format



Single Articles


    August 2017
  1. KHANNA C
    Leveraging Comparative Oncology in the Hopes of Improving Therapies for Breast Cancer.
    Semin Oncol. 2017;44:301.
    PubMed     Text format    


  2. RAPOSO TP, Arias-Pulido H, Chaher N, Fiering SN, et al
    Comparative aspects of canine and human inflammatory breast cancer.
    Semin Oncol. 2017;44:288-300.
    PubMed     Text format     Abstract available


  3. MARKS DK, Kalinsky K
    Bevacizumab in breast cancer: a targeted therapy still in search of a target population.
    Semin Oncol. 2017;44:286-287.
    PubMed     Text format    


  4. VARELLA L, Abraham J, Kruse M
    Revisiting the Role of Bevacizumab in the Treatment of Breast Cancer.
    Semin Oncol. 2017;44:273-285.
    PubMed     Text format     Abstract available


  5. ABDELWAHAB YOUSEF AJ
    Male Breast Cancer: Epidemiology and Risk Factors.
    Semin Oncol. 2017;44:267-272.
    PubMed     Text format     Abstract available


    June 2017
  6. SOURBIER C, Neckers L
    Uncoupling tumor-stroma interactions in breast cancer patients.
    Semin Oncol. 2017;44:235-236.
    PubMed     Text format    


  7. MONTI D, Sotgia F, Whitaker-Menezes D, Tuluc M, et al
    Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer.
    Semin Oncol. 2017;44:226-232.
    PubMed     Text format     Abstract available


  8. CAPOLUONGO E, Ellison G, Lopez-Guerrero JA, Penault-Llorca F, et al
    Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients.
    Semin Oncol. 2017;44:187-197.
    PubMed     Text format     Abstract available


  9. BAS Y, Hassan HA, Adiguzel C, Bulur O, et al
    The distribution of cancer cases in Somalia.
    Semin Oncol. 2017;44:178-186.
    PubMed     Text format     Abstract available


    April 2017
  10. O'SULLIVAN CC, Davarpanah NN, Abraham J, Bates SE, et al
    Current challenges in the management of breast cancer brain metastases.
    Semin Oncol. 2017;44:85-100.
    PubMed     Text format     Abstract available


    February 2017
  11. MARCUS PM, Durham DD
    Commentary on "Screening for breast cancer" by Peairs et al.
    Semin Oncol. 2017;44:73.
    PubMed     Text format    


  12. PEAIRS KS, Choi Y, Stewart RW, Sateia HF, et al
    Screening for breast cancer.
    Semin Oncol. 2017;44:60-72.
    PubMed     Text format     Abstract available


    October 2016
  13. COBAIN EF, Milliron KJ, Merajver SD
    Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer.
    Semin Oncol. 2016;43:528-535.
    PubMed     Text format     Abstract available


    June 2016
  14. TAN AR
    Cutaneous manifestations of breast cancer.
    Semin Oncol. 2016;43:331-4.
    PubMed     Text format     Abstract available


    February 2016
  15. WOJTOWICZ ME, Dunn BK, Umar A
    Immunologic approaches to cancer prevention-current status, challenges, and future perspectives.
    Semin Oncol. 2016;43:161-72.
    PubMed     Text format     Abstract available


  16. WALCOTT FL, Patel J, Lubet R, Rodriguez L, et al
    Hereditary cancer syndromes as model systems for chemopreventive agent development.
    Semin Oncol. 2016;43:134-45.
    PubMed     Text format     Abstract available


  17. LAZZERONI M, DeCensi A
    Alternate dosing schedules for cancer chemopreventive agents.
    Semin Oncol. 2016;43:116-22.
    PubMed     Text format     Abstract available


  18. LEE O, Khan SA
    Novel routes for administering chemoprevention: local transdermal therapy to the breasts.
    Semin Oncol. 2016;43:107-15.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: